NATR

Business Context and Reporting Period

Company: Nature's Sunshine Products, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: March 31, 2009
Business Overview: The Company manufactures and markets herbal products, vitamin and mineral supplements, and personal care products through a direct sales force of independent Distributors and Managers. Operations are divided into three segments: Nature's Sunshine Products (United States and International) and Synergy Worldwide.

Key Financial Metrics

Amounts in thousands, except per share data.

Material Changes vs. Prior Period

• Revenue Decline: Net sales decreased 13.8% to $83.2 million. This was driven by a 22.4% drop in International sales (primarily due to currency devaluation in Russia and Ukraine) and a 6.2% drop in U.S. sales due to economic conditions.
• Operating Loss: The Company reported an operating loss of $2.8 million compared to operating income of $0.9 million in the prior year. Total operating expenses exceeded revenue by 3.4%.
• Cash Flow: Operating cash flow turned negative, using $1.6 million compared to providing $5.0 million in the prior year. This shift is attributed to the operating loss and changes in working capital timing.
• Accounting Correction: The Company corrected a classification error regarding volume rebates in Russia and Ukraine for the prior year (Q1 2008). Rebates were reclassified from expense to a reduction of sales revenue. This adjustment reduced prior year net sales by $2.1 million but had no impact on net loss or cash flows.

Outlook, Risks, and Contingencies

• Foreign Currency Risk: A significant portion of the revenue decline is attributed to the strengthening U.S. dollar against foreign currencies, specifically the Russian ruble and Ukrainian hryvnia. The Company does not use derivative instruments to hedge these risks.
• Legal Proceedings:
  • Class-Action Litigation: A consolidated shareholder class-action lawsuit regarding alleged misrepresentations is in the discovery phase, with a trial scheduled for January 2011. The outcome is unpredictable.
  • SEC/DOJ Investigations: The Company is cooperating with ongoing investigations by the SEC and DOJ regarding prior financial restatements. The Company has accrued approximately $600,000 for potential SEC settlement.
  • Stock Registration: The SEC revoked the registration of the Company's common stock in January 2009. While a new registration statement became effective, broker-dealer market-making capabilities may remain limited.
• Internal Controls: The Company identified three material weaknesses in internal controls (Accounting for Taxes, Financial Reporting Process, and IT Systems) as of December 31, 2008. Remediation is in process, but the weaknesses remained as of March 31, 2009, rendering disclosure controls ineffective.
• Venezuela Risk: The Company holds approximately $4.0 million in Venezuelan bolivars. Currency restrictions and potential designation of Venezuela as a "highly inflationary economy" pose risks to repatriation and earnings translation.

Investor Verification Checklist

• Verify the status of the SEC stock registration revocation and the ability of broker-dealers to make a market in the Company's securities.
• Monitor the progress of remediation for the three identified material weaknesses in internal controls over financial reporting.
• Assess the impact of ongoing currency fluctuations, particularly in Russia, Ukraine, and Venezuela, on future revenue and earnings.
• Review updates on the class-action litigation and the potential financial impact of the SEC/DOJ investigations.
• Confirm the Company's ability to repatriate cash from Venezuela given local currency controls.